PA
IVT icon

PharVision Advisers’s InvenTrust Properties IVT Stock Holding History

PharVision Advisers’s Portfolio IVT Stock Details IVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7,505
Closed -$226K – 395
2024
Q4 		$226K Buy
+7,505
New +$226K 0.19% 254

Other funds holding IVT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PharVision Advisers's IVT Position: Q1 2025 in Review

PharVision Advisers sold out of InvenTrust Properties (IVT) in Q1 2025, closing a stake of 7,505 shares — an estimated $226K sold.

PharVision Advisers first reported a position in IVT in Q4 2024 and held it in 1 quarter. The position peaked at $226K in Q4 2024. 301 funds tracked by Wall St. Rank hold IVT as of Q1 2025.

  • PharVision Advisers reported no remaining InvenTrust Properties position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 7,505 InvenTrust Properties shares in Q1 2025, an estimated $226K.
  • PharVision Advisers first reported a position in InvenTrust Properties in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's InvenTrust Properties position peaked at $226K in Q4 2024.
  • 301 funds tracked by Wall St. Rank held InvenTrust Properties as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.